{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T03:36:01Z","timestamp":1780112161428,"version":"3.54.0"},"reference-count":17,"publisher":"SAGE Publications","issue":"1S","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatitis"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1097\/der.0000000000000686","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T12:46:17Z","timestamp":1608209177000},"page":"S24-S27","source":"Crossref","is-referenced-by-count":20,"title":["Dupilumab in Elderly Patients With Severe Atopic Dermatitis"],"prefix":"10.1177","volume":"32","author":[{"given":"Filomena","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Milanesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Cartocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bruzziches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Tronconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lazzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Massimiliano","family":"D'erme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Bagnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Cinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Rubegni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Flori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,12,17]]},"reference":[{"key":"bib1-20221027","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14656566.2020.1729738","article-title":"Pharmacological management of atopic dermatitis in the elderly","volume":"21","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"bib2-20221027","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2174\/1871528110908050398","article-title":"Atopic dermatitis in the elderly","volume":"8","year":"2009","journal-title":"Inflamm Allergy Drug Targets"},{"key":"bib3-20221027","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/ggi.12771","article-title":"Atopic dermatitis in older adults: a viewpoint from geriatric dermatology","volume":"16","year":"2016","journal-title":"Geriatr Gerontol Int"},{"key":"bib4-20221027","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.4110\/in.2019.19.e37","article-title":"Aging and the immune system: the impact of immunosenescence on viral infection, immunity and vaccine immunogenicity","volume":"19","year":"2019","journal-title":"Immune Netw"},{"key":"bib5-20221027","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/14712598.2020.1722998","article-title":"Efficacy of biologics in atopic dermatitis","volume":"20","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"bib6-20221027","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/bjd.18434","article-title":"Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS) [published online December 1, 2019]","volume":"182","year":"2020","journal-title":"Br J Dermatol"},{"key":"bib7-20221027","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2019.07.074","article-title":"Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study","volume":"82","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"bib8-20221027","first-page":"253","article-title":"Tuscan Consensus on the diagnosis, treatment and follow up of adult atopic dermatitis [published online March 10, 2020]","volume":"155","year":"2020","journal-title":"G Ital Dermatol Venereol"},{"key":"bib9-20221027","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The Eczema Area and Severity Index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group","volume":"10","year":"2001","journal-title":"Exp Dermatol"},{"key":"bib10-20221027","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jaad.2017.04.1082","article-title":"Validation of the Peak Pruritus Numerical Rating Scale: results from clinical studies of dupilumab in adult patients with moderate-to-severe atopic dermatitis","volume":"76","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"bib11-20221027","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use","volume":"19","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"bib12-20221027","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","year":"2016","journal-title":"N Engl J Med"},{"key":"bib13-20221027","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/bjd.18255","article-title":"Keeping an eye on the ocular problems in dupilumab clinical trials","volume":"181","year":"2019","journal-title":"Br J Dermatol"},{"key":"bib14-20221027","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bjd.17869","article-title":"Conjunctivitis in dupilumab clinical trials","volume":"181","year":"2019","journal-title":"Br J Dermatol"},{"key":"bib15-20221027","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2249.2012.04644.x","article-title":"Normal ageing is associated with an increase in TH2 cells, MCP-1 (CCL1) and RANTES (CCL5), with differences in sCD40L and PDGF-AA between sexes","volume":"170","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"bib16-20221027","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"bib17-20221027","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40266-020-00750-5","article-title":"Atopic dermatitis in older adults: a review of treatment options","volume":"37","year":"2020","journal-title":"Drugs Aging"}],"container-title":["Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DER.0000000000000686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:05:35Z","timestamp":1777399535000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,17]]},"references-count":17,"journal-issue":{"issue":"1S","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000686","relation":{},"ISSN":["2162-5220","1710-3568"],"issn-type":[{"value":"2162-5220","type":"electronic"},{"value":"1710-3568","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,17]]}}}